Clarus Lifesciences I, L.P. Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Clarus Lifesciences I, L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Clarus Lifesciences I, L.P.. Clarus Lifesciences I, L.P. is 10% Owner in AVANIR PHARMACEUTICALS, INC. ($AVNR) and 10% Owner in GLOBUS MEDICAL INC ($GMED) and 10% Owner in ZOGENIX, INC. ($ZGNX) and 10% Owner in Oxford Immunotec Global PLC ($OXFD).
Latest Insider Trading Transactions of Clarus Lifesciences I, L.P.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVNR, GMED, OXFD, ZGNX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 25 2013 | OXFD | Oxford Immunotec G ... | Clarus Lifesciences I, L.P. | 10% Owner | Option Exercise | C | 0.00 | 203,439 | 0 | 0 | |
| Nov 25 2013 | OXFD | Oxford Immunotec G ... | Clarus Lifesciences I, L.P. | 10% Owner | Option Exercise | C | 0.00 | 553,859 | 0 | 0 | |
| Nov 25 2013 | OXFD | Oxford Immunotec G ... | Clarus Lifesciences I, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,239,308 | 0 | 0 | |
| Nov 25 2013 | OXFD | Oxford Immunotec G ... | Clarus Lifesciences I, L.P. | 10% Owner | Option Exercise | C | 0.00 | 582,456 | 0 | 0 | |
| Nov 25 2013 | OXFD | Oxford Immunotec G ... | Clarus Lifesciences I, L.P. | 10% Owner | Buy | C | 0.00 | 203,439 | 0 | 2,579,062 | 2.4 M to 2.6 M (+8.56 %) |
| Nov 25 2013 | OXFD | Oxford Immunotec G ... | Clarus Lifesciences I, L.P. | 10% Owner | Buy | C | 0.00 | 553,859 | 0 | 2,375,623 | 1.8 M to 2.4 M (+30.40 %) |
| Nov 25 2013 | OXFD | Oxford Immunotec G ... | Clarus Lifesciences I, L.P. | 10% Owner | Buy | C | 0.00 | 1,239,308 | 0 | 1,821,764 | 582.5 K to 1.8 M (+212.77 %) |
| Nov 25 2013 | OXFD | Oxford Immunotec G ... | Clarus Lifesciences I, L.P. | 10% Owner | Buy | C | 0.00 | 582,456 | 0 | 582,456 | 0 to 582.5 K |
| Sep 04 2013 | GMED | GLOBUS MEDICAL INC | Clarus Lifesciences I, L.P. | 10% Owner | Sell | J | 0.00 | 7,244,201 | 0 | 0 | 7.2 M to 0 (-100.00 %) |
| Aug 10 2012 | GMED | GLOBUS MEDICAL INC | Clarus Lifesciences I, L.P. | 10% Owner | Option Exercise | C | 0.00 | 7,444,168 | 0 | 0 | |
| Aug 10 2012 | GMED | GLOBUS MEDICAL INC | Clarus Lifesciences I, L.P. | 10% Owner | Sell | S | 11.16 | 804,232 | 8,975,229 | 7,244,201 | 8 M to 7.2 M (-9.99 %) |
| Aug 10 2012 | GMED | GLOBUS MEDICAL INC | Clarus Lifesciences I, L.P. | 10% Owner | Buy | C | 0.00 | 7,444,168 | 0 | 8,048,433 | 604.3 K to 8 M (+1,231.94 %) |
| Sep 20 2011 | ZGNX | ZOGENIX, INC. | Clarus Lifesciences I, L.P. | 10% Owner | Buy | P | 2.00 | 3,500,000 | 7,000,000 | 9,482,439 | 6 M to 9.5 M (+58.50 %) |
| Dec 07 2010 | AVNR | AVANIR PHARMACEUTI ... | Clarus Lifesciences I, L.P. | 10% Owner | Sell | J | 0.00 | 6,669,204 | 0 | 12 | 6.7 M to 12 (-100.00 %) |
| Nov 10 2010 | AVNR | AVANIR PHARMACEUTI ... | Clarus Lifesciences I, L.P. | 10% Owner | Sell | S | 4.81 | 1,200,000 | 5,773,920 | 6,669,216 | 7.9 M to 6.7 M (-15.25 %) |
| Nov 10 2010 | AVNR | AVANIR PHARMACEUTI ... | Clarus Lifesciences I, L.P. | 10% Owner | Sell | S | 5.10 | 44,626 | 227,593 | 7,869,216 | 7.9 M to 7.9 M (-0.56 %) |
| Nov 05 2010 | AVNR | AVANIR PHARMACEUTI ... | Clarus Lifesciences I, L.P. | 10% Owner | Sell | S | 4.80 | 332,572 | 1,597,377 | 7,913,842 | 8.2 M to 7.9 M (-4.03 %) |
| Nov 05 2010 | AVNR | AVANIR PHARMACEUTI ... | Clarus Lifesciences I, L.P. | 10% Owner | Sell | S | 4.52 | 1,400,106 | 6,332,539 | 8,246,414 | 9.6 M to 8.2 M (-14.51 %) |
| Nov 02 2010 | AVNR | AVANIR PHARMACEUTI ... | Clarus Lifesciences I, L.P. | 10% Owner | Sell | S | 4.49 | 1,290,871 | 5,800,400 | 9,646,520 | 10.9 M to 9.6 M (-11.80 %) |
| Nov 02 2010 | AVNR | AVANIR PHARMACEUTI ... | Clarus Lifesciences I, L.P. | 10% Owner | Sell | S | 5.36 | 2,478,142 | 13,273,424 | 10,937,391 | 13.4 M to 10.9 M (-18.47 %) |
| Nov 02 2010 | AVNR | AVANIR PHARMACEUTI ... | Clarus Lifesciences I, L.P. | 10% Owner | Sell | S | 5.06 | 1,424,947 | 7,215,647 | 13,415,533 | 14.8 M to 13.4 M (-9.60 %) |
| Oct 12 2010 | AVNR | AVANIR PHARMACEUTI ... | Clarus Lifesciences I, L.P. | 10% Owner | Sell | S | 3.52 | 311,000 | 1,093,445 | 14,840,480 | 15.2 M to 14.8 M (-2.05 %) |
| Oct 12 2010 | AVNR | AVANIR PHARMACEUTI ... | Clarus Lifesciences I, L.P. | 10% Owner | Sell | S | 3.47 | 240,838 | 836,792 | 15,151,480 | 15.4 M to 15.2 M (-1.56 %) |
| Jul 15 2010 | AVNR | AVANIR PHARMACEUTI ... | Clarus Lifesciences I, L.P. | 10% Owner | Sell | S | 3.53 | 165,000 | 583,143 | 15,392,318 | 15.6 M to 15.4 M (-1.06 %) |
Page: 1